The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451 · cited 4×
“These two groups of neurons interact with each other and have reciprocal connections with “second order” neurons in other hypothalamic regions such as the PVN, DMH, VMH and LHA (see Fig.”
BackgroundInfluentialEffectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Binder (2004) · doi:10.1080/08977190410001723308 · Cited by 1,481
Farde, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070032005 · Cited by 1,419
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors
Tecott, L. H., Sun, L. M., Akana, S. F., Strack, A. M., Lowenstein, D. H., Dallman, M. F., & Julius, D. (1995) · Nature · doi:10.1038/374542a0 · Cited by 1,274
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., Laughren, T. P., & Katz, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W. H. M. L., Van Gompel, P., Lesage, A. S., De Loore, K., & Leysen, J. E. (1996) · Psychopharmacology · doi:10.1007/bf02245606 · Cited by 1,167
Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I. P., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60486-9 · Cited by 1,088
Meier, U., & Gressner, A. M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032482 · Cited by 1,035
Hypothalamic lesions and adiposity in the rat
Hetherington, A. W., & Ranson, S. W. (1940) · The Anatomical Record · doi:10.1002/ar.1090780203 · Cited by 1,016
Kroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y., & Roth, B. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300027 · Cited by 801
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
Nasrallah, H. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002066 · Cited by 714
Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels
Spanswick, D., Smith, M. A., Groppi, V. E., Logan, S. D., & Ashford, M. L. J. (1997) · Nature · doi:10.1038/37379 · Cited by 628 · cited 1×
“Studies in an animal model of diabetes (Spanswick et al., 1997) show an impairment of the normal activation of KATP channels in hypothalamic neurons by leptin, which is increased following antipsychotic drug administration.”
BackgroundOsborn, D. P. J., Levy, G., Nazareth, I., Petersen, I., Islam, A., & King, M. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.242 · Cited by 608
Binding of antipsychotic drugs to human brain receptors
Richelson, E., & Souder, T. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00911-5 · Cited by 607
The hypothalamus and the control of energy homeostasis
Williams, G., Bing, C., Cai, X. J., Harrold, J. A., King, P. J., & Liu, X. H. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00612-6 · Cited by 578
Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia
Newcomer, J. W., Haupt, D. W., Fucetola, R., Melson, A. K., Schweiger, J. A., Cooper, B. P., & Selke, G. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.4.337 · Cited by 520
Asenapine: a novel psychopharmacologic agent with a unique human receptor signature
Shahid, M., Walker, G., Zorn, S., & Wong, E. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881107082944 · Cited by 493
Atypical antipsychotics and weightgain — a systematic review
Taylor, D. M., & McAskill, R. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101006416.x · Cited by 433
Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphism
Reynolds, G. P., Zhang, Z.-J., & Zhang, X.-B. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08913-4 · Cited by 412
Self-citationKim, S. F., Huang, A. S., Snowman, A. M., Teuscher, C., & Snyder, S. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611417104 · Cited by 394
(2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0219 · Cited by 383
Dourish, C. T., Hutson, P. H., & Curzon, G. (1985) · Psychopharmacology · doi:10.1007/bf00431709 · Cited by 319
De Hert, M. A., van Winkel, R., Van Eyck, D., Hanssens, L., Wampers, M., Scheen, A., & Peuskens, J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.12.855 · Cited by 314
Smoking as a Modifiable Risk Factor for Type 2 Diabetes in Middle-Aged Men
Wannamethee, S. G., Shaper, A. G., & Perry, I. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1590 · Cited by 314
Metabolic syndrome and mental illness.
Newcomer, J. W. (2007) · PubMed · Cited by 285
Templeman, L. A., Reynolds, G. P., Arranz, B., & San, L. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200504000-00002 · Cited by 267
Self-citationRS-102221: A Novel High Affinity and Selective, 5-HT 2C Receptor Antagonist
BONHAUS, D. W., WEINHARDT, K. K., TAYLOR, M., DESOUZA, A., MCNEELEY, P. M., SZCZEPANSKI, K., FONTANA, D. J., TRINH, J., ROCHA, C. L., DAWSON, M. W., et al. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00049-x · Cited by 251
Zhang, Z.-J., Yao, Z.-J., Liu, W., Fang, Q., & Reynolds, G. P. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.1.58 · Cited by 230
Self-citationGreenman, Y., Tordjman, K., & Stern, N. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00403.x · Cited by 227
Brain-derived neurotrophic factor (BDNF) and food intake regulation: A minireview
Lebrun, B., Bariohay, B., Moyse, E., & Jean, A. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.02.027 · Cited by 219
Zhou, L., Sutton, G. M., Rochford, J. J., Semple, R. K., Lam, D. D., Oksanen, L. J., Thornton-Jones, Z. D., Clifton, P. G., Yueh, C.-Y., Evans, M. L., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.008 · Cited by 213
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze
Woolley, M. L., Bentley, J. C., Sleight, A. J., Marsden, C. A., & Fone, K. C. F. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00056-9 · Cited by 206
Obesity among individuals with serious mental illness
Dickerson, F. B., Brown, C. H., Kreyenbuhl, J. A., Fang, L., Goldberg, R. W., Wohlheiter, K., & Dixon, L. B. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00637.x · Cited by 200
Association of the G-2548A polymorphism in the 5′ region of the LEP gene with overweight
MAMMÈS, O., BETOULLE, D., AUBERT, R., HERBETH, B., SIEST, G., & FUMERON, F. (2000) · Annals of Human Genetics · doi:10.1017/s0003480000008277 · Cited by 199
Reynolds, G. P., Zhang, Z., & Zhang, X. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.677 · Cited by 198
Self-citationMatsui-Sakata, A., Ohtani, H., & Sawada, Y. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.368 · Cited by 191
Goldman, C. K., Marino, L., & Leibowitz, S. F. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90578-3 · Cited by 187
Hormonal and Metabolic Effects of Olanzapine and Clozapine Related to Body Weight in Rodents
Albaugh, V. L., Henry, C. R., Bello, N. T., Hajnal, A., Lynch, S. L., Halle, B., & Lynch, C. J. (2006) · Obesity · doi:10.1038/oby.2006.6 · Cited by 181
Potkin, S. G., & Cohen, M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1004 · Cited by 175
Inverse Agonist Activity of Atypical Antipsychotic Drugs at Human 5-Hydroxytryptamine2C Receptors
Herrick-Davis, K., Grinde, E., & Teitler, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38891-3 · Cited by 173
De Vry, J., & Schreiber, R. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00083-4 · Cited by 167
Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin
Jin, H., Meyer, J. M., Mudaliar, S. R. D., & Jeste, D. V. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.026 · Cited by 165
Arranz, B., Rosel, P., Ramírez, N., Dueñas, R., Fernández, P., Sanchez, J. M., Navarro, M. A., & San, L. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1007 · Cited by 161
The 5-HT2C receptor and antipsychoticinduced weight gain – mechanisms and genetics
Reynolds, G. P., Hill, M. J., & Kirk, S. L. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066040 · Cited by 160
Self-citationJackson, H. C., Bearham, M. C., Hutchins, L. J., Mazurkiewicz, S. E., Needham, A. M., & Heal, D. J. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701311 · Cited by 157
Lecklin, A., Etu-Seppälä, P., Stark, H., & Tuomisto, L. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00186-3 · Cited by 156
Clozapine‐induced weight gain associated with the 5HT2C receptor −759C/T polymorphism
Miller, D. D., Ellingrod, V. L., Holman, T. L., Buckley, P. F., & Arndt, S. V. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30115 · Cited by 155
Johnson, D. E., Yamazaki, H., Ward, K. M., Schmidt, A. W., Lebel, W. S., Treadway, J. L., Gibbs, E. M., Zawalich, W. S., & Rollema, H. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1552 · Cited by 152
Weight gain associated with the −759C/T polymorphism of the 5HT2C receptor and olanzapine
Ellingrod, V. L., Perry, P. J., Ringold, J. C., Lund, B. C., Bever‐Stille, K., Fleming, F. W., Holman, T. L., & Miller, D. D. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20169 · Cited by 147
Clifton, P. G., Lee, M. D., & Dourish, C. T. (2000) · Psychopharmacology · doi:10.1007/s002130000504 · Cited by 147
Silvestre, J. S., & Prous, J. (2005) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2005.27.5.908643 · Cited by 143
A parametric analysis of olanzapine-induced weight gain in female rats
Cooper, G. D., Pickavance, L. C., Wilding, J. P. H., Halford, J. C. G., & Goudie, A. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2224-4 · Cited by 141
Appetite Regulation: An Overview
Dhillo, W. S. (2007) · Thyroid · doi:10.1089/thy.2007.0018 · Cited by 140
Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation
Sakata, T., Ookuma, K., Fukagawa, K., Fujimoto, K., Yoshimatsu, H., Shiraishi, T., & Wada, H. (1988) · Brain Research · doi:10.1016/0006-8993(88)91423-0 · Cited by 140
Mizrahi, R. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.4.630 · Cited by 122
Receptor Mechanisms in the treatment of Schizophrenia
Reynolds, G. P. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800303 · Cited by 118
Self-citationPharmacological Management of Atypical Antipsychotic-Induced Weight Gain
Baptista, T., Fakih, Y. E., Uzcátegui, E., Sandia, I., Tálamo, E., de Baptista, E. A., & Beaulieu, S. (2008) · CNS Drugs · doi:10.2165/00023210-200822060-00003 · Cited by 118
Raeder, M. B., Fernø, J., Vik‐Mo, A. O., & Steen, V. M. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9160-4 · Cited by 117
Zhang, X., Zhou, D. F., Wu, G. Y., Cao, L. Y., Tan, Y. L., Haile, C. N., Li, J., Lü, L., Kosten, T. A., & Kosten, T. R. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301619 · Cited by 115
Hellard, S. L., Theisen, F., Haberhausen, M., Raeder, M. B., Fernø, J., Gebhardt, S., Hinney, A., Remschmidt, H., Krieg, J. C., Mehler‐Wex, C., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002133 · Cited by 115
LEIBOWITZ, S. F., Roossin, P. S., & Rosenn, M. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(84)80022-2 · Cited by 111
Ellingrod, V. L., Miller, D. D., Taylor, S. F., Moline, J., Holman, T. L., & Kerr, J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.030 · Cited by 107
Autoimmune diseases in the pedigrees of schizophrenic and control subjects
Wright, P., Sham, P. C., Gilvarry, C. M., Jones, P. B., Cannon, M. D., Sharma, T., & Murray, R. M. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(96)82950-1 · Cited by 105
Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats
Parada, M. A., Hernandez, L., & Hoebel, B. G. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90120-7 · Cited by 102
Tarazi, F. I., Zhang, K., & Baldessarini, R. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1016-3 · Cited by 102
Han, M., Deng, C., Burne, T. H. J., Newell, K. A., & Huang, X. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.01.018 · Cited by 100
Fernø, J., Skrede, S., Vik‐Mo, A. O., Håvik, B., & Steen, V. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-69 · Cited by 94
Mulder, H., Franke, B., van der, A. A. V. D. B., Arends, J., Wilmink, F. W., Scheffer, H., & Egberts, T. C. G. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3180a76dc0 · Cited by 94
Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors
Kirk, S. L., Glazebrook, J., Grayson, B., Neill, J. C., & Reynolds, G. P. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1639-8 · Cited by 92
Self-citationMüller, D. J., Klempan, T., Luca, V. D., Sicard, T., Volavka, J., Czobor, P., Sheitman, B., Lindenmayer, J., Citrome, L., McEvoy, J. P., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.037 · Cited by 91
Blundell, J. E., & Leshem, M. (1975) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1975.tb09374.x · Cited by 88
Clifton, P. G., Rusk, I. N., & Cooper, S. J. (1991) · Behavioral Neuroscience · doi:10.1037//0735-7044.105.2.272 · Cited by 87
Yevtushenko, O. O., Cooper, S. J., O'Neill, R., Doherty, J. K., Woodside, J. V., & Reynolds, G. P. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.041723 · Cited by 87
Self-citationMcCabe, J. T., DeBellis, M. D., & LEIBOWITZ, S. F. (1984) · Brain Research · doi:10.1016/0006-8993(84)91013-8 · Cited by 86
Emsley, R. A., Berwaerts, J., Eerdekens, M., Kramer, M. L., Lane, R., Lim, P., Hough, D., & Palumbo, J. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328314e1f3 · Cited by 86
Pérez‐Iglesias, R., Vázquez‐Barquero, J. L., Amado, J., Berja, A., García‐Unzueta, M. T., Pelayo‐Terán, J. M., Carrasco-Marín, E., Mata, I. F., & Crespo‐Facorro, B. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b8e6 · Cited by 83
CYP2D6 polymorphisms and atypical antipsychotic weight gain
Ellingrod, V. L., Miller, D. D., Schultz, S. K., Wehring, H. J., & Arndt, S. V. (2002) · Psychiatric Genetics · doi:10.1097/00041444-200203000-00008 · Cited by 81
Wang, Y.-C., Bai, Y., Chen, J., Lin, C.-C., Lai, I., & Liou, Y. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000175600.26893.fa · Cited by 80
Raclopride reduces sucrose preference in rats
Hsiao, S., & Smith, G. P. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00315-n · Cited by 79
Park, Y., Chung, Y.-C., Lee, S., Lee, K., Kim, H., Byun, Y., Lim, S., Paik, J., & Lee, H. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30311 · Cited by 75
Casey, D. E., Sands, E. E., Heisterberg, J., & Yang, H.-M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1207-7 · Cited by 72
Analysis of dopamine d1 and d2 receptor involvement in d- and l-amphetamine-induced anorexia in rats
Gilbert, D. B., & Cooper, S. J. (1985) · Brain Research Bulletin · doi:10.1016/0361-9230(85)90006-1 · Cited by 71
Heart and Soul: Stress and the Metabolic Syndrome
Björntorp, P. A. (2001) · Scandinavian Cardiovascular Journal · doi:10.1080/140174301750305045 · Cited by 68
Chagnon, Y. C., Mérette, C., Bouchard, R.-H., Émond, C., Roy, M.-A., & Maziade, M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001537 · Cited by 67
张志珺, 姚志剑, 牟晓冬, Chen, J.-F., 朱荣鑫, Liu, W., 张向荣, 孙静, & 侯钢 (2003) · PubMed · Cited by 57
The Distribution of Adipose Tissue in Female In-patients Receiving Psychotropic Drugs
STEDMAN, T. J., & Welham, J. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.162.2.249 · Cited by 56
Zhang, J. Y., Kowal, D. M., Nawoschik, S. P., Lou, Z., & Dunlop, J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.007 · Cited by 56
Goudie, A. J., Halford, J. C. G., Dovey, T. M., Cooper, G. D., & Neill, J. C. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300291 · Cited by 56
5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity
Hill, M., & Reynolds, G. P. (2007) · Brain Research · doi:10.1016/j.brainres.2007.02.038 · Cited by 53
Self-citationHong, C., Lin, C., Yu, Y. W. ‐., Chang, S.-C., Wang, S.-Y., & Tsai, S. (2002) · Psychiatric Genetics · doi:10.1097/00041444-200209000-00009 · Cited by 51
Murashita, M. M., Kusumi, I., Hosoda, H., Kangawa, K., & Koyama, T. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.05.007 · Cited by 51
Mackin, P., & Thomas, S. (2011) · BMJ · doi:10.1136/bmj.d1126 · Cited by 48
Audinot, V., Newman-Tancredi, A., Cussac, D., & Millan, M. J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00237-8 · Cited by 46
Agonist diversity in 5-HT2C receptor-mediated weight control in rats
Hayashi, A., Suzuki, M., Sasamata, M., & Miyata, K. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2019-z · Cited by 45
Blockade of 5-HT2a Receptors Reduces Haloperidol-Induced Attenuation of Reward
Benaliouad, F., Kapur, S., & Rompré, P.-P. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301136 · Cited by 44
Wellman, P. J., & Davies, B. T. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90452-l · Cited by 44
Dupuis, D. S., la Cour, C. M., Chaput, C., Verrièle, L., Lavielle, G., & Millan, M. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.04.039 · Cited by 42
Smith, R. C., Segman, R. H., Golcer-Dubner, T., Павлов, В. Н., & Lerer, B. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500474 · Cited by 39
Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat
Kirk, S. L., Neill, J. C., Jones, D. N. C., & Reynolds, G. P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.015 · Cited by 39
Self-citationAsenapine induces differential regional effects on serotonin receptor subtypes
Tarazi, F. I., Moran‐Gates, T., Wong, E., Henry, B., & Shahid, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108095704 · Cited by 39
Baptista, T., Alastre, T., Contreras, Q., Martinez, J., de Baptista, E., Páez, X., & Hernández, L. (1997) · Pharmacopsychiatry · doi:10.1055/s-2007-979502 · Cited by 37
Theisen, F., Haberhausen, M., Firnges, M. A., Gregory, P., Reinders, J., Remschmidt, H., Hebebrand, J., & Antel, J. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500418 · Cited by 35
Chagnon, Y. C., Bureau, A., Gendron, D., Bouchard, R.-H., Mérette, C., Roy, M., & Maziade, M. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30554 · Cited by 33
Zhang, Z., Yao, Z., Zhang, X., Chen, J., Sun, J., Yao, H., Hou, G., & Zhang, X.-B. (2003) · PubMed · Cited by 32
Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus
Kirk, S. L., Cahir, M., & Reynolds, G. P. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106061199 · Cited by 30
Self-citationZiprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats
Snigdha, S., Thumbi, C., Reynolds, G. P., & Neill, J. C. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107081519 · Cited by 30
Self-citationTirupati, S., & Chua, L.-E. (2007) · Australasian Psychiatry · doi:10.1080/10398560701636906 · Cited by 30
Best, L. C., Yates, A. P., & Reynolds, G. P. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105056641 · Cited by 29
Self-citationDavoodi, N., Kalinichev, M., & Clifton, P. G. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282f62c66 · Cited by 21
Walker, M. (1984) · PubMed · Cited by 20
Aripiprazole Improves Metabolic Adversity in Olanzapine-Treated Schizophrenic Patients
Chen, C.-H., Huang, M., & Lu, M. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31814fb9a3 · Cited by 14
Risperidone reduces mRNA expression levels of Sulfonylurea Receptor 1 and TASK1 in PC12 cells
Ota, M., Nakashima, A., Kaneko, Y. S., Mori, K., Takami, G., & Ota, A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.11.018 · Cited by 7
Cited by
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820
“monozygotic twin and sibling studies, suggests that genetic factors play an important role in medication-induced weight gain (43-45), with estimates as high as 60-80% for antipsychotic-related weight gain (46).”
BackgroundBegriche, K., Massart, J., Robin, M.-A., Borgne-Sanchez, A., & Fromenty, B. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.006 · Cited by 555
Dopamine receptors –IUPHAR R eview 13
Beaulieu, J., Espinoza, S., & Gainetdinov, R. R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12906 · Cited by 521
Metadata
- Authors
- Reynolds, G. P., & Kirk, S. L.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 125
- Issue
- 1
- Pages
- 169-179
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1968223004
- Cited by
- 401
- References
- 116
- FWCI
- 16.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.